Yissum - Research Development Company of the Hebrew University

A Universal Imaging tool to Test the Efficacy of Anti-Corona Drugs

Posted by Yissum - Research Development Company of the Hebrew UniversityResponsive · Innovative Products and Technologies · Israel

Summary of the technology

A Universal Imaging tool to Test the Efficacy of Anti-Corona Drugs
Project ID : 47-2020-10896

Yissum - Research Development Company of the Hebrew University

Description of the technology

We propose an imaging tool that will test the efficacy of a wide range of potential COVID-19 drugs. The imaging tool will enable high-resolution imaging of the infection process of a large number of single cells, by single virus sub-units (virions).

The types of drugs that can be tested will include those with small molecules and antibodies, targeted both against the virus proteins and against the infected cells at every stage of infection and development of the virus (i.e. before infection, at the time of infection, and afterwards). The efficacy test will be carried out quantitatively and comparatively, with and without the drug.

The efficacy testing will be based on an innovative technology developed at the Hebrew University, in the laboratory of Professor Eilon Sherman, who specializes in optical microscopy in super resolution. Prof. Sherman’s technology enables high resolution and controlled imaging of the interactions between cells, viruses and viral proteins.

To date, this technology has been demonstrated to work on numerous biological and clinical systems. The tool is expected to dramatically accelerate drug development and does not require involvement of human subjects or animal testing.

It has major advantages in terms of saving resources (money, equipment, etc.) as well as time required for the screening and development of antiviral drugs. Such advantages are critical for the rapid introduction of drugs into the market, as the cost of the development of any drug is valued at an average of 10 years and billions of dollars.

Project manager

Shani (Formal Employee) Bullock (Formal Employee)
VP, Business Development, Healthcare

Project researchers

Eilon Sherman
HUJI, Faculty of Science
The Racah Institute of Physics

Related keywords

  • Infectious Diseases
  • Biological Sciences
  • Virus, Virology / Antibiotics / Bacteriology
  • In vitro Testing, Trials Technology
  • Imaging, Image Processing, Pattern Recognition
  • Covid-19
  • covid-19

About Yissum - Research Development Company of the Hebrew University

Technology Transfer Office from Israel

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Founded in 1964 to protect and commercialize the Hebrew University’s intellectual property. Ranked among the top technology transfer companies, Yissum has registered over 8,900 patents covering 2,500 inventions; has licensed out 800 technologies and has spun-off 90 companies. Products that are based on Hebrew University technologies and were commercialized by Yissum generate today over $2 Billion in annual sales.

Send your request

By clicking "Send your request" you are signing up and accepting our Terms of Service and Privacy policy

Technology Offers on Innoget are directly posted and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.